🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to characterize the clinical effects of tislel...
Status
Recruiting
Location
Helios Clinical Research
Start Date
2026-04-30
Trial ID
NCT07554521
Treatments Being Tested
The Phase 1b study is an open-label, multicenter dose escalation study desi...
Status
Completed
Location
ARENSIA Exploratory Medicine LLC
Start Date
2017-08-30
Trial ID
NCT02795988
The aim of this study is to compare outcomes in Chinese patients with local...
Status
Recruiting
Location
Anyang Tumor Hospital
Start Date
2016-11
Trial ID
NCT02972372
The purpose of this study is to evaluate the efficacy of pembrolizumab (MK-...
Status
Withdrawn
Location
Cancer Hospital Chinese Academy of Medical Sciences ( Site 2421)
Start Date
2018-11-08
Trial ID
NCT04859582
Treatments Being Tested
In this clinical trial, if the doctor knows or suspects that a growth in th...
Status
Completed
Location
University of Cincinnati Cancer Center
Start Date
2011-11
Trial ID
NCT01726582
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of pembrolizumab (MK-...
Status
Completed
Location
UCLA Hematology/Oncology - Westwood (Building 200 Suite 120) ( Site 0124)
Start Date
2018-11-08
Trial ID
NCT03675737
Treatments Being Tested